The biodistribution and pharmacokinetic evaluation of choline-bound gold nanoparticles in a human prostate tumor xenograft model

Clinical and Investigative Medicine

Volumn 36, Issue 3, 2013, Pages 133-142

  Razzak, Rene ^a   Zhou, Joe ^b   Yang, XiaoHong ^b   Pervez, Nadim ^b   Bédard, Eric L R ^c   Moore, Ronald B ^b   Shaw, Andrew ^b   Amanie, John ^b   Roa, Wilson H ^b  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^b CROSS CANCER INSTITUTE   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84880028509     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: 10.25011/cim.v36i3.19724     Document Type: Article

References (40)

1. Hainfeld J F, Dilmanian FA, Slatkin D N, et al. Radiotherapy enhancement with gold nanoparticles. J Pharm Pharmacol 2008;60:977-985.
2. Hainfeld J F, Dilmanian F A, Zhong Z, et al. Gold nanoparticles enhance the radiation therapy of a murine squamous cell carcinoma. Phys Med Biol 2010;55:3045-3059.
3. Cho S H, Jones B L and Krishnan S. The dosimetric feasibility of gold nanoparticle-aided radiation therapy (GNRT) via brachytherapy using low-energy gamma-/x-ray sources. Phys Med Biol 2009;54:4889-4905.
4. Roeske J C,Nunez L,Hoggarth M, et al. Characterization of the theorectical radiation dose enhancement from nanoparticles Technol. Cancer Res. Treat. 2007; 6: 395-401.
5. Zhang S X, Gao J, Buchholz T A, et al. Quantifying tumor selective radiation dose enhancements using gold nanoparticles: a Monte Carlo simulation study. Biomed Microdevice 2009;11:925-933.
6. Jones BL, Krishnan S and Cho SH. Estimation of microscopic dose enhancement factor around gold nanoparticles by Monte Carlo calculations. Med Phys 2010;37: 3809-3816.
7. Herold D M, Das I J, Stobbe C C, et al. Gold microspheres: a Selective technique for producing biologically effective dose enhancement. Int J Radiat Biol 2000;76:1357-1364.
8. Hainfeld J F, Slatkin D N and Smilowitz H M. The use of gold nanoparticles to enhance radiotherapy in mice. Phys. Med. Biol. 2004. 49: N309-15.
9. Roa W, Zhang X, Xing J, et al. Gold nanoparticle sensitize radiotherapy of prostate cancer cells by regulation of the cell cycle. Nanotechnology 2009:20, 375101-375111
10. Chattopadhyay N, Cai Z, Pignol JP, et al. Design and Characterization of HER-2-Targeted Gold Nanoparticles for Enhanced X-radiation Treatment of Locally Advanced Breast Cancer. Mol. Pharm 2010:7(6): 2194-2206.
11. Dreaden EC, Mwakwari SC , Sodji QH, et al. Tamoxifenpoly( ethylene glycol)-thiol gold nanoparticle conjugates: enhanced potency and selective delivery for breast cancer treatment. Bioconjug Chemistry 2009;20:2247-53.
12. Glazer ES, Zhu C, Massey KL, et al. Noninvasive Radiofrequency Field Destruction of Pancreatic Adenocarcinoma Xenografts Treated with Targeted Gold Nanoparticles. Clin Cancer Res; 2010:16(23);5712-21.
13. Zeisel SH. Dietary choline: biochemistry, physiology, and pharmacology. Annu Rev Nutr 1981;1: 95-121.
14. Kurhanewicz J, Vigneron DB, Hricak H, et al. Three dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. Radiology 1996;198:795-805.
15. Ackerstaff E, Pflug BR, Nelson JB, et al. Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. Cancer Res 2001;61:3599-3603.
16. Ramirez dM A, Rodriguez-Gonzalez A, Gutierrez R, et al. Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. Biochem Biophys Res Commun 2002; 296: 580-583.
17. Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon-11choline. J Nucl Med 1998;39:990-5.
18. Jong IJ, Pruim J, Elsinga PH, et al. Visualization of prostate cancer with [11C]choline positron emission tomography. Eur Urol 2002;42:18-23.
19. Kotzerke J, Prang J, Neumaier B, et al. Experience with carbon-11 choline positron emission tomography in prostate carcinoma. Eur J Nucl Med 2000; 27:1415-1419.
20. Roivainen A, Forsback S, Gronroos T, et al. Blood metabolism of [methyl-11C] choline; implications for in vivo imaging with positron emission tomography. Eur J Nucl Med 2000;27:25-32.
21. Godbey WT and Mikos AG. Recent progress in gene delivery using non-viral transfer complexes. J Control Release 2001;72:115-125.
22. Godbey WT, Wu KK, Mikos AG. Poly(ethylenimine) and its role in gene delivery. J Control Release 1999;60:149-160.
23. Kichler A, Leborgne C, Coeytaux E, et al. Polyethyleniminemediated gene delivery: a mechanistic study. J Gene Med 2001;3:135-144.
24. Kulkarni RP, Mishra S, Fraser SE, et al. Single cell kinetics of intracellular nonviral, nucleic acid delivery vehicle acidification and trafficking. Bioconjug Chem 2005;16:986-994.
25. Akinc A, Thomas M, Klibanov AM, et al. Exploring polyethylenimine- mediated DNA transfection and the proton sponge hypothesis. J Gene Med 2005;7:657.
26. Elbakry A, Wurster EC, Zaky E, et al. Layer-by-layer coated gold nanoparticles: size-dependent delivery of DNA into cells. Small 2012;8(24):3847-3856.
27. McBain S, Yiu H, El Haj A, et al. Polyethyleneimine functionalized ironoxide nanoparticles as agents for DNA delivery and transfection. J Mater Chem 2007;17(24):2561-2565.
28. Kamper SG, Porter-Peden L, Blankespoor R, et al. Investigating the Specific Interactions between Carbonic Anhydrase and a Sulfonamide Inhibitor by Single- Molecule Force Spectroscopy. Langmuir 2007;23:12561-12565.
29. Vitale F, Fratoddi I, Battocchio C, et al. Mono- and bifunctional arenethiols as surfactants for gold nanoparticles: synthesis and characterization. Nanoscale Research Letters 2011;6:103.
30. Zhang H, Evans SD, Henderson JR, et al. Spectroscopic Characterization of Gold Nanoparticles Passivated by Mercaptopyridine and Mercaptopyrimidine Derivatives; J. Phys. Chem. B 2003;107:6087-6095.
31. Tlili A, Abdelghani A, Hleli S and Maaref MA. Electrical Characterization of a Thiol SAM on Gold as a First Step for the Fabrication of Immunosensors based on a Quartz Crystal Microbalance. Sensors 2004;4:105-114.
32. Rofstad E K and Brustad T. Tumor growth delay following single dose irradiation of human melanoma xenographs: correlations with tumor growth parameters, vasculature structure, and cellular radiosensitivity. Br J Cancer 1985;51:201-210.
33. Zhang G, Yang Z and Lu W. Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor xenografted mice. Biomaterials 2009;30:1928-1936.
34. Hillyer JF and Albrecht RM. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J Pharm Sci 2001;90:1927-1936.
35. Ji ZQ, Sun H, Wang H, et al. Biodistribution and tumor uptake of C60(OH)x in mice. J Nanopart Res 2006;8:53-63.
36. Nemmar A and Hoet PH, Vanquickenborne B, et al. Passage of inhaled particles into the blood circulation in humans. Circulation 2002;105: 411-414.
37. Oberdorster G, Sharp Z, Atudorei V, et al. Extrapulmonary translocation of ultrafine carbon particles following whole- body inhalation exposure of rats. J Toxicol Environ Health 2002;65:1531-1543.
38. Glazer ES, Zhu CH, Hamir AN, et al. Biodistribution and acute toxicity of naked gold nanoparticles in a rabbit hepatic tumor model. Nanotoxicology 2010; 1-10.
39. Jong WH, Hagens WI, Burger MC, et al. Particle sizedependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 2008;29:1912-1919
40. Semmler-Behnke M, Kreyling WG, Lipka J, et al. Biodistribution of 1.4 nm and 18 nm gold particles in rats. Small 2008;4:2108-2111.